| 英文别名 |
17BETA-HYDROXY-4-ANDROSTEN-3-ONE 17-ENANTHATE;17b-hydroxyandrost-4-en-3-one-17-ethanate;4-ANDROSTEN-17BETA-OL-3-ONE 17-ENANTHATE;4-ANDROSTEN-17-BETA-OL-3-ONE ENANTHATE;TESTOSTERONE ENANTATE;TESTOSTERONE ENANTHATE;TESTOSTERONE HEPTANOATE;TESTOSTERONE HEPTYLATE;17-[(1-Oxoheptyl)oxy]androst-4-en-3-one;17-Hydroxyandrost-4-en-3-one, 17-heptanoate;3-Oxoandrost-4-en-17-yl heptanoate;Andro L.A. 200;Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17beta)-;Androst-4-en-3-one, 17beta-hydroxy-, heptanoate;Androtardyl;Atlatest;component of Androgyn l.a.;component of Deladumone;component of Ditate;component of Mal-O-Fem L.A;Atlates;Delatest;Delatestryl;Everone;Exten test;reposotmd;Testate;testenate;Testinon;testosterone ananthane;testosterone oenanthate;Testosterone enantate for system suitability;Testosterone enantate for peak identification;TESTOSTERONE ENANTHATE COMPONENT OF DITATE-DS;17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid;Ditate (Salt/Mix);Testosterone enanthate, analytical standard;17-heptanoyl-17beta-hydroxyandrost-4-en-3-one;17-((1-Oxoheptyl)oxy)androst-4-en-3-one;Testosterone, heptanoate;17beta-Hydroxyandrost-4-en-3-one enanthate;AKOS015960945;Testosterone enanthate [USP:JAN];Androst-4-en-3-one, 17-((1-oxoheptyl)oxy)-, (17beta)-;Testanthate;Reposo TMD;DTXCID901474730;DePatestrye;Androst-4-en-3-one,(17.beta.)-;EINECS 206-253-5;4-Androsten-3-one 17beta-enanthate;Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard;Testosterone heptoic acid;17.BETA.-(HEPTANOYLOXY)ANDROST-4-EN-3-ONE [WHO-IP];Testosterone ethanate;SCHEMBL42687;[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate;Malogen L.A.;Heptanoic acid, ester with testosterone;LMST02020075;(8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate;TESTOSTERONE ENANTATE (MART.);Malogen L.A.200;C08157;TESTOSTERONE ENANTHATE CIII [USP-RS];Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)-;Androgyn L.A. (Salt/Mix);CHEMBL1200335;Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard;NSC17591;7Z6522T8N9;Testosterone 17-heptanoate;BRD-K89657519-001-01-8;Testosterone enanthate (JP17/USP);TESTOSTERONE ENANTHATE [USP MONOGRAPH];TESTOSTERONE ENANTHATE CIII (USP-RS);315-37-7;s3717;Testoenant;DITATE-DS COMPONENT TESTOSTERONE ENANTHATE;Testonenant;TESTOSTERONI ENANTAS [WHO-IP LATIN];3-Oxoandrost-4-en-17-yl heptanoate, (17.beta.)- #;CCG-268655;Testosterone enanthate ciii;CCRIS 7082;CHEBI:9464;Xyosted (Autoinjector);TESTOSTERONE ENANTATE [WHO-IP];Androst-4-en-3-one, 17.beta.-hydroxy-, heptanoate;UNII-7Z6522T8N9;Testostroval;Delatestryl (TN);Depo-Testro Med;4-Androsten-3-one 17.beta.-enanthate;TESTOSTERONE ENANTATE (EP MONOGRAPH);Andropository;Testosterone e... |
